Cardax
Manufacturing · Hawaii, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
2800 Woodlawn Dr Ste 129, Honolulu, Hawa...Phone Number
(808) 457-1400Website
www.cardaxpharma.comRevenue
<$5 MillionStock Symbol
CDXIIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About Cardax
Cardax, Inc., a life sciences company, develops and commercializes consumer health and pharmaceutical products for anti-inflammatory benefits primarily in Hawaii. The company offers ZanthoSyn, an astaxanthin dietary supplement that supports joint, cardiovascular, metabolic, and liver health. It also develops astaxanthin, an anti-inflammatory for arthritis, cognitive decline, metabolic syndrome, triglyceride reduction, hepatic disease, atherosclerosis, and thrombosis diseases; zeaxanthin esters for macular degeneration and hepatic disease; and lycophyll esters for prostate disease, as well as glucocorticoid steroids and NSAIDs. The company sells its products primarily through e-commerce and wholesale channels. It has a joint development and supply agreement with BASF SE, as well as a collaboration agreement with Capsugel US, LLC for the development of astaxanthin products for the consumer health market. The company is based in Honolulu,...Explore more
Cardax Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Cardax your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Cardax, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Cardax
Click to see if Cardax had a recent Job posting/layoffs
Earning: See what the market has to say on Cardax recently announced quarterly report
Check out if Cardax is spiking on competitors!
Product Launch: Get notified when Cardax launches new products
Funding: Get notified immidiatlly once Cardax has new funding data
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Cardax has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at Cardax
Find 2 more new buyers
Compare Similar Companies to Cardax
Compare insights from companies similar to Cardax, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Cardax is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Cardax is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Cardax.
Cardax financials insights
Gather financial insights about Cardax, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2013
Debt
$781K
2014
Debt
$2.1M
2020
Debt
$150K
Cardax Tech Stack
A closer look at the technologies used by Cardax
Cardax News & Media
Cardax Refocuses on ZanthoSyn® Consumer Health Business
HONOLULU, Aug. 31, 2021 /PRNewswire/ -- Cardax, Inc., announced today that it is refocusing its business strategy on its astaxanthin dietary supplement ZanthoSyn® for consumer health. The Company aims to rebuild consumer sales with a reduced corporate cost structure to improve operating...Cardax Voluntarily Suspends SEC Reporting Obligations
HONOLULU, Aug. 11, 2021 /PRNewswire/ -- Cardax, Inc. (OTCQB:CDXI) announced today the filing of a Form 15 with the U.S. Securities and Exchange Commission (the "SEC") to voluntarily suspend its reporting obligations under Section 15(d) of the Securities Exchange Act of 1934 (the "Exchange...Cardax Reports Q1 2021 Results
HONOLULU, May 14, 2021 /PRNewswire/ -- Cardax, Inc. (OTCQB:CDXI) reported its Q1 2021 results. Highlights: Financial Results. Operating loss decreased from $906,031 in Q1 2020 to $771,312 in Q1 2021 primarily due to reduced salaries & wages, professional fees, stock based compensation,...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Cardax
Sign Up For FreeTo access detailed company insights
Cardax, Inc., a life sciences company, develops and commercializes consumer health and pharmaceutical products for anti-inflammatory benefits primarily in Hawaii. The company offers ZanthoSyn, an astaxanthin dietary supplement that supports joint, cardiovascular, metabolic, and liver health. It also develops astaxanthin, an anti-inflammatory for ar... Read More
